Literature DB >> 12852871

Vasoactive responses of veins isolated from the human placental chorionic plate.

M Wareing1, S L Greenwood, M J Taggart, P N Baker.   

Abstract

The control of the blood flow within the fetoplacental circulation is poorly understood despite the essential role of the placenta in pregnancy. Our aim was to assess the vasoactive responses of veins from the placental chorionic plate. Biopsies were obtained from term placentae from uncomplicated pregnancies. Small veins from the chorionic plate were dissected free from surrounding tissue and studied using parallel wire myography. Human placental chorionic plate veins developed maintained constrictions to the thromboxane-mimetic U46619. Endothelium-dependent agonists did not promote venous relaxation. However, NO donation with the endothelial-independent agent, sodium nitroprusside, elicited significant relaxation. Venous constriction to U46619 and relaxation to sodium nitroprusside were modified by adjustment of media oxygen tension and normalization parameters. Human placental chorionic plate veins respond to vasoactive agents and may play a role in the control of the blood flow in the fetoplacental circulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12852871     DOI: 10.1016/s0143-4004(03)00108-5

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  2 in total

1.  Impairment of BKca channels in human placental chorionic plate arteries is potentially relevant to the development of preeclampsia.

Authors:  Mengzhou He; Fanfan Li; Meitao Yang; Yao Fan; Rajluxmee Beejadhursing; Yin Xie; Yuan Zhou; Dongrui Deng
Journal:  Hypertens Res       Date:  2017-11-16       Impact factor: 3.872

2.  DNA methylation-reprogrammed oxytocin receptor underlies insensitivity to oxytocin in pre-eclamptic placental vasculature.

Authors:  Xiaorong Fan; Ting Xu; Hongmei Ding; Huan Li; Yuxian Yang; Yun He; Jiaqi Tang; Yanping Liu; Xueyi Chen; Jie Chen; Jianying Tao; Zhice Xu; Qinqin Gao
Journal:  J Cell Mol Med       Date:  2019-04-04       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.